Published 2 days ago • loading... • Updated 2 days ago

Did GLP-1 drugs kill keto? The new dietary guidelines say not so fast

Brands are removing 'Keto' from packaging, replacing the label with 'High-protein' and 'low-sugar' identifiers as the cultural identity fades; yet the underlying eating habits—cutting refined carbs and prioritizing protein—remain dominant in 2026.
GLP-1 drugs like Ozempic and Wegovy now saturate American health culture, with 1 in 8 adults utilizing the medications, making the strict, macro-tracking demands of traditional Keto diet unnecessary for many consumers.
Federal nutrition policy caught up earlier this year, formally acknowledging for the first time that lower-carbohydrate diets may benefit people managing chronic diseases; the 2025-2030 Dietary Guidelines now prioritize protein and healthy fats over refined carbohydrates.
The protein snacks market is projected to grow to $5.86 billion this year and reach $8.87 billion by 2030, as food brands developing products for GLP-1 users focus on smaller portions and higher protein.
Pharmaceutical medicine and Dietary Guidelines have converged on the same strategy: cutting refined carbs and prioritizing whole foods, with Protein-forward, lower-carb eating now the dominant nutritional framework for the year.

Insights by Ground AI

32 Articles

KULR-TV

+31 Reposted by 31 other sources

Center

Did GLP-1 drugs kill keto? The new dietary guidelines say not so fast

GLP-1 drugs are now a fixture of American health culture: 1 in 8 U.S. adults is taking a medication like Ozempic or Wegovy, and the ... Read moreThe post Did GLP-1 drugs kill keto? The new dietary guidelines say not…

2 days ago·Billings, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year